Cancer Vaccine Market by Type (Preventive Cancer Vaccines, Personalized Cancer Vaccines, Therapeutic Cancer Vaccines); by Technology (Recombinant Cancer Vaccines, Dendritic Cells (DC) Cancer Vaccines, Viral Vector & DNA Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines); by Indication; by End- Users; and by Region (North America, Europe, Asia Pacific, Latin America, MEA); - Global Forecasts 2021 to 2027

Date : Oct 2021

|

Report ID : 476

|

Category : Biotechnology

|
Report Format:  PDF EXCEL PPT WORD

The Global Cancer Vaccine Market size was valued at USD 4.6 Bn in 2020 and is expected to reach USD 9.0 Bn by 2027, growing at a CAGR of 10.0% during the forecast period. Cancer vaccines are a fundamental part to support the immune system, as they are natural reaction modifiers. Cancer vaccines prevent the development of cancer or treat existing cancer. Cancer vaccinations stimulate the immunity system of the patients to destroy the cancer cells.

Cancer Vaccine Market Dynamics

The main driving factors for the growth of the cancer vaccine market are the increasing prevalence of cancers, entry of generic vaccines, and the rising cases of cancer among the old-age population.  Moreover, increasing uptake of cancer vaccines due to rising awareness among the population is the boosting factor for the growth of the global market. Furthermore, increasing research activities in the field of cancer vaccines to treat and prevent cancer is another driving factor influencing the growth of the targeted market.

Cancer Vaccine Market Size

However, the strict regulation for approval of cancer vaccines by the government and alternative available therapies are expected to impede the growth of the cancer vaccine market. The presence of a strong pipeline for the cancer vaccine can create lucrative opportunities for the growth of the global market. High cost of cancer vaccine is expected to be the challenging factor for the adoption of cancer vaccine in developing regions.

The Global Cancer Vaccine Market Segmentation:

By Type

  • Preventive Cancer Vaccines
  • Personalized Cancer Vaccines
  • Therapeutic Cancer Vaccines

By Technology

  • Recombinant Cancer Vaccines
  • Dendritic Cells (DC) Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines

By Indication

  • Cervical Cancers
  • Prostate Cancers
  • Others

By End-Users

  • Pediatric
  • Adults

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on type, the therapeutic cancer vaccines segment is expected to dominate the global cancer vaccine market growth due to expected entry of various products

Based on the type, the targeted market has been segmented into preventive cancer vaccines, therapeutic cancer vaccines, and personalized cancer vaccines. The therapeutic cancer vaccine segment held the highest share in 2020. The increasing demand for therapeutics cancer vaccines due to rising awareness about cancer vaccines and growing incidence of cancer. Therapeutic cancer vaccines worked by activating the immune system to fight against infections. However, the preventive cancer vaccine segment is expected to grow in targeted market at the highest CAGR during the forecast period.

Based on technology, recombinant cancer vaccines are expected to dominate the global cancer vaccine market due to the increased prevalence of cancer

Based on the type, the global market has been segmented into recombinant cancer vaccines, dendritic cells (DC) cancer vaccines, viral vector & DNA cancer vaccines, and antigen/adjuvant cancer vaccines. The recombinant cancer vaccine is expected to dominate the global market in 2020. The increasing prevalence of cancer, coupled with the launch of new recombinant cancer vaccine for the treatment of cancer, is expected to drive this segment. The International Agency for Research on Cancer estimates that the global incidence of cancer is estimated to reach around 29.5 million by 2040, from 18.1 million in 2018. 

Geographically, the North America region dominated in the global cancer vaccine market

In 2020, the North America region dominated the cancer vaccine market owing to the increasing prevalence of cancer patients pool in the region and high healthcare expenditure. Advanced technology in the manufacturing and development process of vaccines and high awareness about cancer vaccines that gives rise to the demand for vaccines are some other factors that are expected to drive the of the cancer vaccine market in the North America region.

Company Profiles and Competitive Intelligence

The key players operating in the cancer vaccine market are:

  • Advaxis Inc.
  • Amgen Inc.
  • Dynavax Technologies Corporation
  • Generex Biotechnology Corporation
  • GlaxoSmithKline plc (GSK)
  • Immunocellular Therapeutics, Ltd
  • Merck & Co., Inc.
  • Sanpower Group Co. Ltd. (Dendereon Corporation)
  • UbiVac
  • Vaccinogen, Inc.
  • Oxford BioMedica
  • Transgene
  • Sotio
  • Aduro Biotech
  • Oncovir
  • OncoThyreon
  • Dandreon
  • Altor BioSciences
  • Agenus
  • Prsima BioMed

The report also provides an in-depth analysis of the global cancer vaccine market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

  • Increasing prevalence cancer
  • Increasing awareness about a cancer vaccine
  • Increasing research activities for the development of cancer vaccine
  • Increasing geriatric population

Restraints

  • Strict regulation for approval of cancer vaccine
  • Presences of alternative therapies

Opportunities

  •  Presences of strong pipeline

Challenges

  •   High cost of cancer vaccines

COVID-19 Impact on the Global Cancer Vaccine Market Analysis

COVID-19 has highly affected the industries in terms of growth, economy, health, and mental well-being of every individual. In this challenging situation, every industry is trying to give the best services in terms of quality and safety. The outbreak of COVID-19 has affected negatively on the healthcare industry and the cancer vaccine market growth.

During the pandemic, the focus of pharmaceutical & biopharmaceutical companies shifted towards the research & development, and production of COVID-19 vaccines therefore, the funding for the development of cancer vaccines hinder.

The report also provides an in-depth analysis of key trends in the global cancer vaccine market

  • Increasing awareness about cancer vaccines among the population
  • Rising expenditure on research and development activities for improving technologies in developing countries related to cancer vaccine

The report also provides an in-depth analysis of recent news developments and investments

  • In September 2021, NantWorks LLC has signed a collaboration agreement with the Council for Scientific and Industrial Research (CSIR) and other African research centers that will begin the transfer of biologic manufacturing technology for cancer vaccines, COVID-19, and next-generation cell-based immunotherapies across the Africa.
  • In December 2020, Anixa Biosciences, California-based biotech organization collaborated with Cleveland Clinic, and received USFDA investigational new medication application for its new breast cancer vaccine innovation created by Cleveland Clinic immunologist Dr. Vincent Tuohy and his examination group to begin the primary human clinical preliminaries to prevent the breast cancer.

The unique insights provided by the global market report also includes the following:

  • In-Depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • COVID-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impact on The Global Cancer Vaccine Market Growth
  • Competitive Landscape

Frequently Asked Questions (FAQs)

What is the size of global cancer vaccine market?

The global cancer vaccine market is estimated to be USD 4.6 Bn in 2020 and is expected to reach USD 9.0 Bn by 2027.

What is the estimated market growth rate of the global cancer vaccine market?

The global market is estimated to grow at a compound annual growth rate (CAGR) of 10.0% during the forecast period.

Which region accounted for the largest share in the global market?

North America accounted the largest share in the global market.

What is the factor that hampers the growth of global market?

Unfavorable price of drugs is the hampering factor for the growth of the global market.

What are the major driving factors for the growth of the global market?

Increasing incidence of cancers and growing awareness about the vaccines are the major driving factors for the growth of the global market.

Which is the base year provided in the report of the global cancer vaccine market?

The 2020 is the base year provided in the report of the global cancer vaccine market.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1. INTRODUCTION
    1. Product Outline
    2. What is Cancer Vaccine?
    3. Different Types of Cancer Vaccine
    4. Supply Chain Analysis
    5. COVID -19 Impact
    6. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
  2. Regulatory Landscape for Global Cancer Vaccine Market 
    1. Regulations and Standards
  3. Global Cancer Vaccine Market by Type
    1. Preventive Cancer Vaccines
    2. Personalized Cancer Vaccines
    3. Therapeutic Cancer Vaccines
  4. Global Cancer Vaccine Market by Technology
    1. Recombinant Cancer Vaccines
    2. Dendritic Cells (DC) Cancer Vaccines
    3. Viral Vector & DNA Cancer Vaccines
    4. Antigen/Adjuvant Cancer Vaccines
  5. Global Cancer Vaccine Market by Indications
    1. Cervical Cancer
    2. Prostate Cancer
    3. Others
  6. Global Cancer Vaccine Market by End-Users
    1. Pediatrics
    2. Adults
  7. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Rest Of Asia Pacific
    4. Middle East and Africa (MEA)
      1. GCC
      2. Rest of MEA
    5. South America
      1. Brazil
      2. Mexico
      3. Rest of South America
  8. Key Strategic Insights
    1. New Development
    2. Opportunity Mapping
    3. Critical Success Factors
    4. Customer Preferences 
  9. Key Market Trends / Recent Developments
  10. Competitive Scenario
    1. Competitive Strategies of Key Players
      1. Mergers and Acquisitions
      2. Investments
      3. Joint Ventures
    2. Ranking of Key Players
  11. Key Global Players
    1. Advaxis Inc.
    2. Amgen Inc.
    3. Dynavax Technologies Corporation
    4. Generex Biotechnology Corporation
    5. GlaxoSmithKline plc (GSK)
    6. Immunocellular Therapeutics, Ltd
    7. Merck & Co., Inc.
    8. Sanpower Group Co. Ltd. (Dendereon Corporation)
    9. UbiVac
    10. Vaccinogen, Inc.
    11. Oxford BioMedica
    12. Transgene
    13. Sotio
    14. Aduro Biotech
    15. Oncovir

Choose License
Buy Now
Why Choose AllTheResearch?
  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on “Quadrant Positioning” of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports. Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.


Quick Inquiry
Follow Us
Choose License
Buy Now